Power3 Medical Products, Inc. (PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials.

Alzheimer’s disease isn’t an ordinary part of getting older, even though greatest known risk factor is increasing age, along with the largest part of people today with Alzheimer’s tend to be 65 and older. But Alzheimer’s is not just a sickness of old age. Up to 5 % of people with the sickness currently have early-onset Alzheimer’s (also referred to as younger-onset), which frequently appears in people in their 40s or 50s.

Soon after cancer of the skin, cancer of the breast is easily the most well-known cancer diagnosed in females in the USA. However breast cancer rates have gone down, though doctors aren’t certain why. Even now, for many females, breast cancer may be the health probem that they fear most.

Parkinson’s disease is really a problem that affects nerve cells, or neurons, inside of a section of the brain of which controls muscle motions. In Parkinson’s, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist synchronize a person’s activities.

******************************************

American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that it has signed an option agreement to acquire two claim blocks in townships of Mekinac and Lajuene, Province of Quebec.

These claim blocks are approximately 3600 acres in total and are located 120 miles east of Montreal P.Q. and 50 miles north of Three Rivers P.Q. They are accessible year round with infrastructure in the immediate vicinity. The claims adjoin a property that had one of the highest readings of Rare Earths in North America. Sampling in the 1950s gave readings of 48% combined Cerium, Lanthanum, Neoymium and Yttrium.

That property has remained dormant for over 50 years but the new owners plan an extensive exploration program this fall. American Video, after a lengthy search and after careful due diligence, believes this is going to be one of the most active areas for Rare Earths exploration and our holdings are in the same geological setting as the 48% Rare Earths showing.

Rare Earths are in huge demand especially in the United States as China is closing off its exports of these strategic metals to less than 5% of its production. American Video will aggressively continue to search world wide for opportunities in Precious, Base and Rare Earths metal projects.

The 17 elements that are classified as “rare earth” are becoming an increasingly crucial aspect of our day-to-day lives. Rare earth metals are definitely the life blood of modern computers, batteries and alternative energies. For instance, you’ll find nearly 10 pounds of the rare earth element, lanthanum, in each and every Toyota Prius engine.

******************************************
Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) announced results for the fiscal year (FY) second quarter ended October 31, 2010. Received $245,000 grant under the Patient Protection and Affordable Care Program Act. Secured listing on leading on-line beauty retail websites for DERMACYTE skin care products: Dermstore.com and Beautyriche.com. Granted DSMB Approval to proceed to second cohort of STOP-TBI Phase II-b trials. In November, the Company issued a promissory note under Note Purchase Agreement with Vatea Fund in the amount of $600,000.

Oxygen Biotherapeutics, Inc. develops medical and cosmetic products that deliver oxygen to tissues in the body. It develops a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte that is being formulated for both intravenous and topical delivery for conditions, including but not limited to traumatic brain injury, decompression sickness, cosmetics, and topical wounds.

******************************************

Ampal-American Israel Corp. (Nasdaq:AMPL) announced that it has been advised by East Mediterranean Gas Co. (”EMG”), in which Ampal has a 12.5% interest, that EMG signed five Gas Sale Agreements with Oil Refineries Ltd., O.P.C Rotem Ltd., IC Power Ltd. and Dead Sea Works Ltd. The Agreements are for a total quantity of 1.4 billion cubic meters (“BCM”) annually for 20 years, with an option to buyers to increase the total quantity up to 2.9 BCM annually. The option is to be exercised by March 31, 2011 with the exception of one agreement stating that the option is to be exercised by December 31, 2011. The total value of the five contracts is between $5 to $10 Billion. Gas delivery is scheduled to commence between the first and second quarters of 2011.

Ampal-American Israel Corporation acquires interests in businesses located in the State of Israel or that are Israel-related. It invests in companies in telecommunications, real estate and project development, energy, leisure time, and high technology sectors. The company provides its investee companies with ongoing support through its involvement in the investees' strategic decisions and introduction to the financial community, investment bankers, and other potential investors both in and outside of Israel. Ampal is a New York corporation founded in 1942 and is headquartered in New York, New York.

******************************************

Graymark Healthcare, Inc. (Nasdaq:GRMH) has closed the previously announced sale of substantially all the assets of its ApothecaryRx’s retail pharmacy business to Walgreens Co. (NYSE:WAG). ApothecaryRx operated 18 pharmacies across five states. The transaction allows Graymark to focus on its core business of providing comprehensive care for sleep disorders, primarily obstructive sleep apnea, including diagnosis, therapy, and ongoing clinical and product support.

Graymark Healthcare, Inc. operates independent retail pharmacy stores that sell prescription drugs and a small assortment of general merchandise in the United States. The company operates in two segments, ApothecaryRx and Sleep Management Solutions (SMS). The ApothecaryRx segment engages in the retail sale of prescription drugs, non-prescription drugs, and health related products, including diabetic merchandise, beauty products and cosmetics, seasonal merchandise, greeting cards, convenience foods, compounded pharmaceuticals, and durable medical equipment.

*************************************************************

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup

*************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) anticipates to receive 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (AVOT.PK) from the company for 12 months IR Services.